EUVIMEDEUVIMED entdecken
Crossref

S‐Allyl‐Cysteine Ameliorates Cirrhotic Portal Hypertension by Enhancing Lymphangiogenesis via a VEGF ‐C‐Independent Manner

Guqing Luo, Zhenghao Wu, Qiang Fan, Chihao Zhang iD, Jiayun Lin, Hongjie Li, Jinbo Zhao, Haizhong Huo, Xiaoliang Qi, Guangbo Wu, Min Chen, Jiwei Yu und 2 weitere

Liver International · 2025-03 · 45 (3)

DOI: 10.1111/liv.70024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 18.02.2025. Verfasst von Guqing Luo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Lymphangiogenesis, Hypertension, Portal, Vascular Endothelial Growth Factor C, Cysteine. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Postdoctoral Scientific Research Foundation of Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Clinical Research Program of 9th People's Hospital, Shanghai Jiao Tong University School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Lymphangiogenesis is enhanced during the development of liver cirrhosis and portal hypertension (PHT). However, hepatic lymphatic vascular system is understudied in liver cirrhosis and PHT. Hydrogen sulfide (H 2 S) and related compounds have potential prolymphangiogenic effects besides its previously reported vascular‐protective effects. Therefore, we aimed to investigate the effects of endogenous H 2 S donor S‐allyl‐cysteine (SAC) on bile duct ligation (BDL)‐induced liver cirrhosis and PHT.

Methods

BDL rats with cholestatic liver cirrhosis and PHT were orally administrated with SAC at 100 or 200 mg/kg/day, as well as DL‐propargylglycine (PAG) or MAZ‐51 injections. Hemodynamic parameters were determined, and subsequent evaluations of liver fibrosis, intrahepatic vascular resistance (IHVR) and lymphangiogensis were performed. Human lymphatic endothelial cells (hLECs) were used for in vitro verification of prolymphangiogenic effects of SAC.

Results

SAC treatment significantly decreased PP and promoted endogenous H 2 S production. Liver fibrosis and IHVR were also ameliorated. Hepatic and mesenteric lymphangiogenesis were enhanced in BDL rats and further promoted by SAC despite a significant downregulation of hepatic VEGF‐C. Inhibition of H 2 S production by PAG significantly reduced lymphatic vessels, while inhibition of lymphangiogensis by MAZ‐51 reversed the protective effects of SAC against PHT. SAC enhanced lymphangiogenic functions in vitro by promoting cellular H 2 S production and activating Akt phosphorylation without altering VEGF‐C/D, which were reversed by PAG and MAZ‐51.

Conclusions

SAC significantly alleviated BDL‐induced liver cirrhosis and PHT. Meanwhile, elevated H 2 S induced by SAC facilitated lymphangiogenesis via a VEGF‐C‐independent manner, which contributed to the alleviation of PHT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphangiogenesisHypertension, PortalVascular Endothelial Growth Factor CCysteineLiver CirrhosisAnimalsMaleRatsHydrogen SulfideHumansRats, Sprague-DawleyEndothelial CellsVascular ResistanceLiverDisease Models, Animal

Stichwörter der Autor:innen

S‐allyl‐cysteinehydrogen sulfideliver cirrhosislymphangiogenesisportal hypertension

Substanzen

Vascular Endothelial Growth Factor CCysteineHydrogen SulfideS-allylcysteine

Autor:innen und Institutionen

  • Department of General Surgery, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

ORCID-Profile: Chihao Zhang, Meng Luo

Förderung

  • National Natural Science Foundation of China
  • Postdoctoral Scientific Research Foundation of Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
  • Clinical Research Program of 9th People's Hospital, Shanghai Jiao Tong University School of Medicine
  • Shanghai Municipal Commission of Health and Family Planning
  • the Fundamental research program funding of Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine
  • Science Foundation of Xinjiang Uygur Natural Autonomous Region
  • Clinical Research MDT Program of 9th People's Hospital, Shanghai Jiao Tong University School of Medicine

Zitieren

APA

Luo, G., Wu, Z., Fan, Q., Zhang, C., Lin, J., Li, H., Zhao, J., Huo, H., Qi, X., Wu, G., Chen, M., Yu, J., Zheng, L., & Luo, M. (2025). S‐Allyl‐Cysteine Ameliorates Cirrhotic Portal Hypertension by Enhancing Lymphangiogenesis via a VEGF ‐C‐Independent Manner. Liver International, 45(3). https://doi.org/10.1111/liv.70024

Vancouver

Luo G, Wu Z, Fan Q, Zhang C, Lin J, Li H, et al. S‐Allyl‐Cysteine Ameliorates Cirrhotic Portal Hypertension by Enhancing Lymphangiogenesis via a VEGF ‐C‐Independent Manner. Liver International. 2025;45(3). doi:10.1111/liv.70024

BibTeX
@article{Luo2025,
  author = {Luo, Guqing and Wu, Zhenghao and Fan, Qiang and Zhang, Chihao and Lin, Jiayun and Li, Hongjie and Zhao, Jinbo and Huo, Haizhong and Qi, Xiaoliang and Wu, Guangbo and Chen, Min and Yu, Jiwei and Zheng, Lei and Luo, Meng},
  title = {S‐Allyl‐Cysteine Ameliorates Cirrhotic Portal Hypertension by Enhancing Lymphangiogenesis via a VEGF ‐C‐Independent Manner},
  journal = {Liver International},
  year = {2025},
  volume = {45},
  number = {3},
  doi = {10.1111/liv.70024}
}
Kostenlos starten →